TME cells may release growth factors and cytokines such as WNT, epidermal growth factor, TNF, IL-17, and IL-6 in response to therapy-induced tumour cell death, which promotes the survival of residual tumour cells and leads to treatment resistance (6). Here, IL6 is linked to neoplasm.